Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAP3K4 |
| Upstream (Parents) |
|---|
| (<<) BZW2 → MAP3K4 |
| (<<) DNM1L → MAP3K4 |
| (<<) FGFR2 → MAP3K4 |
| (<<) GNB2L1 → MAP3K4 |
| (<<) GYPC → MAP3K4 |
| (<<) HDAC2 → MAP3K4 |
| (<<) ITGAE → MAP3K4 |
| (<<) LTA4H → MAP3K4 |
| (<<) PLCG1 → MAP3K4 |
| (<<) PPRC1 → MAP3K4 |
| (<<) SAA4 → MAP3K4 |
| (<<) SET → MAP3K4 |
| (<<) UGDH → MAP3K4 |
| Downstream (Children) |
|---|
| MAP3K4 → ARSD (>>) |
| MAP3K4 → CCNL1 (>>) |
| MAP3K4 → CLCF1 (>>) |
| MAP3K4 → FZD10 (>>) |
| MAP3K4 → FZD9 (>>) |
| MAP3K4 → GNA15 (>>) |
| MAP3K4 → GNE (>>) |
| MAP3K4 → HDAC9 (>>) |
| MAP3K4 → IL1A (>>) |
| MAP3K4 → ILKAP (>>) |
| MAP3K4 → RRP15 (>>) |
| MAP3K4 → RYK (>>) |
| MAP3K4 → TPP1 (>>) |
| MAP3K4 → TXNIP (>>) |
